{"id":23876,"date":"2013-09-20T12:51:17","date_gmt":"2013-09-20T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23876"},"modified":"2018-04-14T02:09:25","modified_gmt":"2018-04-14T07:09:25","slug":"23876","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23876\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 20 de setembro de 2013"},"content":{"rendered":"

vers\u00e3o impressa<\/a><\/p>\n

***********************************
\nBrakke Consulting's
\nNot\u00edcias e notas sobre sa\u00fade animal de 20 de setembro de 2013<\/strong>
\nCopyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon DVM MBA
\n************************************
\nNAS NOTICIAS:
\n 
\nNovidades da Brakke Consulting<\/u>
\ncanal OTC<\/p>\n

not\u00edcias de ganhos<\/u>
\nAnpario
\n 
\noutras not\u00edcias<\/u>
\nTecnologia Celular Avan\u00e7ada
\nElanco
\nHeska
\nLuitpold
\nNovartis
\nHospital Eq\u00fcino Rood & Riddle
\nValent BioCi\u00eancias
\nVetnique Labs
\n 
\n************************************
\nBRAKKE CONSULTING, INC.
\nENTENDENDO O MERCADO DE BOLSA<\/strong><\/p>\n

Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea distribui nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais OTC de distribui\u00e7\u00e3o. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas l\u00e1 e as oportunidades existentes, entre em contato com nosso escrit\u00f3rio em Dallas ou Joel Adamson em jadamson@brakkeconsulting.com<\/a>.
\n 
\nwww.BrakkeConsulting.com<\/a>
\n 
\n***********************************
\nRELEASES DE RESULTADOS DA EMPRESA
\n 
\n> A Anpario plc anunciou os resultados do primeiro semestre de 2013. A receita de vendas aumentou 20% para 13,0 milh\u00f5es de libras esterlinas ($19,8 milh\u00f5es). O lucro antes de impostos do primeiro semestre aumentou para 1,51 milh\u00e3o de libras esterlinas ($2,3 milh\u00f5es) em rela\u00e7\u00e3o aos 0,9 milh\u00f5es de libras esterlinas do ano anterior. (RTTNot\u00edcias) 
\n 
\n************************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA
\n 
\n> A Elanco Companion Animal Health anunciou o lan\u00e7amento do Recuvyra, uma solu\u00e7\u00e3o transd\u00e9rmica de fentanil que proporciona controle da dor p\u00f3s-operat\u00f3ria com nova aplica\u00e7\u00e3o transd\u00e9rmica. Uma dose \u00fanica aplicada na regi\u00e3o dorsal da esc\u00e1pula de c\u00e3es antes da cirurgia foi projetada para controlar a dor por quatro dias. (DVM360)
\n 
\n> Heska Corporation anunciou o lan\u00e7amento do Element POC. Este analisador de sangue r\u00e1pido, port\u00e1til e sem fio de \u00faltima gera\u00e7\u00e3o fornece testes r\u00e1pidos de gases sangu\u00edneos, eletr\u00f3litos, metab\u00f3litos e qu\u00edmica b\u00e1sica do sangue. (WSJOn-line)
\n 
\n> A Luitpold Animal Health anunciou que uma remessa de Adequan IM foi lan\u00e7ada no mercado na semana passada; no entanto, o fornecimento do produto Adequan permanece limitado. A empresa relata que est\u00e1 trabalhando diligentemente para lan\u00e7ar produtos adicionais no mercado. (comunicado de imprensa da empresa) 
\n 
\n> A Valent BioSciences Corporation anunciou que recebeu a patente n\u00ba 8.536.224 do Escrit\u00f3rio de Patentes e Com\u00e9rcio dos EUA para o uso terap\u00eautico de \u00e1cido S-absc\u00edsico (S-ABA) e certos derivados em aplica\u00e7\u00f5es selecionadas de sa\u00fade humana e animal. (Transfer\u00eancia de Mercado)
\n 
\n> Advanced Cell Technology, Inc. anunciou que entrou com um pedido de investiga\u00e7\u00e3o de novo medicamento animal (INAD) junto ao FDA para testar suas c\u00e9lulas-tronco mesenquimais propriet\u00e1rias \u201cprontas para uso\u201d para uma s\u00e9rie de indica\u00e7\u00f5es de doen\u00e7as inflamat\u00f3rias e imunomediadas. (Transfer\u00eancia Comercial)
\n 
\n> Vetnique Labs LLC lan\u00e7ou o suplemento nutricional Glandex. Glandex fornece suporte \u00e0s gl\u00e2ndulas anais e ajuda os animais de estima\u00e7\u00e3o a manter as gl\u00e2ndulas anais saud\u00e1veis, produzindo fezes volumosas e firmes para ajudar as gl\u00e2ndulas anais a se esvaziarem naturalmente. Glandex tamb\u00e9m cont\u00e9m ingredientes essenciais para combater inflama\u00e7\u00f5es e alergias subjacentes que desencadeiam problemas nas gl\u00e2ndulas anais. (comunicado de imprensa da empresa) 
\n 
\n> O Rood & Riddle Equine Hospital anunciou que expandiu seus servi\u00e7os veterin\u00e1rios para Nova York. Localizada em Saratoga Springs, a cl\u00ednica \u2013 que ser\u00e1 conhecida como Saratoga Equine: A Rood & Riddle Hospital \u2013 \u00e9 o primeiro empreendimento cl\u00ednico da Rood & Riddle fora de Kentucky. (TheHorse. com)
\n 
\n> A EU Novartis Animal Health Inc. anunciou que Onsior (robenacoxib) recebeu aprova\u00e7\u00e3o da Comiss\u00e3o Europeia para o tratamento da dor e inflama\u00e7\u00e3o associadas \u00e0 cirurgia ortop\u00e9dica em gatos. A formula\u00e7\u00e3o injet\u00e1vel do Onsior j\u00e1 est\u00e1 aprovada para o tratamento da dor e inflama\u00e7\u00e3o associada \u00e0 cirurgia de tecidos moles em gatos. (comunicado de imprensa da empresa) 
\n 
\n***********************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL
\n 
\n> EUA \u2013 PEDV Cientistas da Iowa State University desenvolveram um novo teste para detectar anticorpos contra o V\u00edrus da Diarr\u00e9ia Epid\u00eamica Su\u00edna (PEDV). O novo teste \u00e9 um anticorpo de imunofluoresc\u00eancia ou ensaio de anticorpo fluorescente indireto, que utiliza amostras de sangue. Os pesquisadores afirmam que o teste \u00e9 capaz de informar aos veterin\u00e1rios e produtores se um porco j\u00e1 teve a doen\u00e7a no passado e se ainda est\u00e1 disseminando o v\u00edrus. Estar\u00e1 dispon\u00edvel para produtores regionais de su\u00ednos e seus veterin\u00e1rios atrav\u00e9s do Laborat\u00f3rio de Diagn\u00f3stico Veterin\u00e1rio da Universidade Estadual de Iowa. (Farm\u00e1cia Animal)
\n 
\n> EUA \u2013 OVOS ARTIFICIAIS A Hampton Creek Foods anunciou o lan\u00e7amento de ovoprodutos vegetais nos EUA. O ovo artificial \u00e9 uma mistura de diferentes plantas, incluindo canola, ervilha e lecitina de girassol, e seu criador diz que sua produ\u00e7\u00e3o custa 18% menos do que ovos reais. Duas linhas \u2013 uma maionese sem ovo e um ovo em p\u00f3 para panifica\u00e7\u00e3o \u2013 est\u00e3o sendo vendidas inicialmente nas lojas Whole Foods. (Vantagem veterin\u00e1ria)
\n 
\n> ESC\u00d3CIA \u2013 VACINA E COLI Cientistas da Universidade de Glasgow, na Esc\u00f3cia, publicaram uma pesquisa sugerindo que a vacina\u00e7\u00e3o do gado contra Escherichia coli O157 poderia reduzir o n\u00famero de casos da doen\u00e7a em pessoas em at\u00e9 85%. O estudo, publicado na revista online PNAS, utilizou dados veterin\u00e1rios, humanos e moleculares. O risco de infec\u00e7\u00e3o por E. coli O157 \u00e9 particularmente significativo quando o gado est\u00e1 em \u201csuper elimina\u00e7\u00e3o\u201d, e as vacinas contra a bact\u00e9ria podem reduzir a super elimina\u00e7\u00e3o. (Alimentos)
\n 
\n***********************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n

H\u00e1 algumas hist\u00f3rias no boletim informativo desta semana relacionadas a tecnologias e produtos de diagn\u00f3stico novos ou aprimorados. O diagn\u00f3stico de animais de companhia e de alimenta\u00e7\u00e3o continua sendo uma das \u00e1reas de sa\u00fade animal que mais cresce. Geralmente \u00e9 mais barato diagnosticar problemas de sa\u00fade decorrentes do tratamento precoce do animal do que esperar at\u00e9 que surja uma crise que pode n\u00e3o ser trat\u00e1vel.<\/p>\n

No in\u00edcio desta semana, o USDA aumentou suas previs\u00f5es para a produ\u00e7\u00e3o de milho e soja em 2013. Estima-se agora que a colheita de milho deste ano poder\u00e1 ser a maior de sempre. Este relat\u00f3rio traz algumas boas not\u00edcias para os produtores de prote\u00edna animal e para as empresas que utilizam milho e soja em seus produtos acabados. Esta \u00e9 uma boa not\u00edcia para a ind\u00fastria de sa\u00fade animal e para os consumidores. N\u00e3o demorar\u00e1 muito at\u00e9 que as colheitadeiras comecem a rolar pelos campos e ent\u00e3o saberemos a precis\u00e3o das \u00faltimas previs\u00f5es.<\/p>\n

Tenha um bom fim de semana!!<\/p>\n

Ron Brakke
\n 
\n**********************************<\/p>\n

Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.
\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n12005 Ford Rd., Suite 530
\nDallas, TX 75234 EUA<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

vers\u00e3o impressa *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 20 de setembro de 2013 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NO NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre ganhos do canal OTC Anpario outras not\u00edcias Tecnologia celular avan\u00e7ada Elanco Heska Luitpold Novartis Rood & Riddle Equine Hospital Valent BioSciences Vetnique Labs ********************** ************** BRAKKE CONSULTING, INC. ENTENDENDO O MERCADO DE Balc\u00e3o Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou se voc\u00ea distribui nos canais OTC h\u00e1 anos , a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade \u00e0s empresas que buscam aprender mais sobre os detalhes dos canais de distribui\u00e7\u00e3o OTC. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas neles e as oportunidades existentes, entre em contato com nosso escrit\u00f3rio em Dallas ou com Joel Adamson em jadamson@brakkeconsulting.com. www.BrakkeConsulting.com *********************************** DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA > Anpario plc anunciou resultados para o primeiro semestre de 2013. A receita de vendas aumentou 20% para GBP 13,0 milh\u00f5es ($19,8 milh\u00f5es). O lucro antes de impostos do primeiro semestre aumentou para 1,51 milh\u00e3o de libras esterlinas ($2,3 milh\u00f5es) em rela\u00e7\u00e3o aos 0,9 milh\u00f5es de libras esterlinas do ano anterior. (RTTNews) ************************************ COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA > Elanco Companion Animal Health anunciou o lan\u00e7amento do Recuvyra, uma solu\u00e7\u00e3o transd\u00e9rmica de fentanil que proporciona controle da dor p\u00f3s-operat\u00f3ria com nova administra\u00e7\u00e3o transd\u00e9rmica. Um \u00fanico<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23876","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23876\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting’s Animal Health News & Notes for September 20, 2013 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC channel earnings news Anpario   other news Advanced Cell Technology Elanco Heska Luitpold Novartis Rood & Riddle Equine Hospital Valent BioSciences Vetnique Labs   ************************************ BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > Anpario plc announced results for the first half of 2013. Sales revenue increased 20% to GBP 13.0 million ($19.8 million). First-half pre-tax profit rose to GBP 1.51 million ($2.3 million) from the prior year’s GBP 0.9 million. (RTTNews)    ************************************ COMPANY NEWS RELEASES   > Elanco Companion Animal Health announced the launch of Recuvyra, a transdermal fentanyl solution that provides post-operative pain control with new transdermal delivery. A singleView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23876\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-20T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:09:25+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for September 20, 2013\",\"datePublished\":\"2013-09-20T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/\"},\"wordCount\":1037,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23876\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2013-09-20T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:25+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23876\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23876\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for September 20, 2013\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23876\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting’s Animal Health News & Notes for September 20, 2013 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC channel earnings news Anpario   other news Advanced Cell Technology Elanco Heska Luitpold Novartis Rood & Riddle Equine Hospital Valent BioSciences Vetnique Labs   ************************************ BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > Anpario plc announced results for the first half of 2013. Sales revenue increased 20% to GBP 13.0 million ($19.8 million). First-half pre-tax profit rose to GBP 1.51 million ($2.3 million) from the prior year’s GBP 0.9 million. (RTTNews)    ************************************ COMPANY NEWS RELEASES   > Elanco Companion Animal Health announced the launch of Recuvyra, a transdermal fentanyl solution that provides post-operative pain control with new transdermal delivery. A singleView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23876\/","og_site_name":"Brakke Consulting Website","article_published_time":"2013-09-20T17:51:17+00:00","article_modified_time":"2018-04-14T07:09:25+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23876\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23876\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for September 20, 2013","datePublished":"2013-09-20T17:51:17+00:00","dateModified":"2018-04-14T07:09:25+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23876\/"},"wordCount":1037,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23876\/","url":"https:\/\/brakkeconsulting.com\/23876\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2013-09-20T17:51:17+00:00","dateModified":"2018-04-14T07:09:25+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23876\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23876\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23876\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for September 20, 2013"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23876"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23876\/revisions"}],"predecessor-version":[{"id":25422,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23876\/revisions\/25422"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}